These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32573759)

  • 21. SEMIPARAMETRIC QUANTILE REGRESSION WITH HIGH-DIMENSIONAL COVARIATES.
    Zhu L; Huang M; Li R
    Stat Sin; 2012 Oct; 22(4):1379-1401. PubMed ID: 24501536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A semiparametric approach for the nonparametric transformation survival model with multiple covariates.
    Song X; Ma S; Huang J; Zhou XH
    Biostatistics; 2007 Apr; 8(2):197-211. PubMed ID: 16670240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accounting for interactions and complex inter-subject dependency in estimating treatment effect in cluster-randomized trials with missing outcomes.
    Prague M; Wang R; Stephens A; Tchetgen Tchetgen E; DeGruttola V
    Biometrics; 2016 Dec; 72(4):1066-1077. PubMed ID: 27060877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causal effect models for realistic individualized treatment and intention to treat rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 3. PubMed ID: 19122793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating optimal individualized treatment rules with multistate processes.
    Bakoyannis G
    Biometrics; 2023 Dec; 79(4):2830-2842. PubMed ID: 37015010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal treatment assignment to maximize expected outcome with multiple treatments.
    Lou Z; Shao J; Yu M
    Biometrics; 2018 Jun; 74(2):506-516. PubMed ID: 29088515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model-free screening for variables with treatment interaction.
    Bizuayehu SB; Xu J
    Stat Methods Med Res; 2022 Oct; 31(10):1845-1859. PubMed ID: 35635269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying optimal biomarker combinations for treatment selection through randomized controlled trials.
    Huang Y
    Clin Trials; 2015 Aug; 12(4):348-56. PubMed ID: 25948620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees.
    Logan BR; Sparapani R; McCulloch RE; Laud PW
    Stat Methods Med Res; 2019 Apr; 28(4):1079-1093. PubMed ID: 29254443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of subgroups via partial linear regression modeling approach.
    Zhou Y; Yuan A; Tan MT
    Biom J; 2022 Mar; 64(3):506-522. PubMed ID: 34897799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semiparametric Bayesian analysis of censored linear regression with errors-in-covariates.
    Sinha S; Wang S
    Stat Methods Med Res; 2017 Jun; 26(3):1389-1415. PubMed ID: 25882297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum likelihood estimation in the additive hazards model.
    Lu C; Goeman J; Putter H
    Biometrics; 2023 Sep; 79(3):1646-1656. PubMed ID: 36124563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semiparametric estimation of the attributable fraction when there are interactions under monotonicity constraints.
    Wang W; Small DS; Harhay MO
    BMC Med Res Methodol; 2020 Sep; 20(1):236. PubMed ID: 32957931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semiparametric analysis of a generalized linear model with multiple covariates subject to detection limits.
    Chen LW; Fine JP; Bair E; Ritter VS; McElrath TF; Cantonwine DE; Meeker JD; Ferguson KK; Zhao S
    Stat Med; 2022 Oct; 41(24):4791-4808. PubMed ID: 35909228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of treatment effects based on possibly misspecified Cox regression.
    Hattori S; Henmi M
    Lifetime Data Anal; 2012 Oct; 18(4):408-33. PubMed ID: 22527680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A corrected smoothed score approach for semiparametric accelerated failure time model with error-contaminated covariates.
    Song X
    Stat Med; 2023 Sep; 42(22):4043-4055. PubMed ID: 37443445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating average treatment effects with a double-index propensity score.
    Cheng D; Chakrabortty A; Ananthakrishnan AN; Cai T
    Biometrics; 2020 Sep; 76(3):767-777. PubMed ID: 31797368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marginal Structural Models with Counterfactual Effect Modifiers.
    Zheng W; Luo Z; van der Laan MJ
    Int J Biostat; 2018 Jun; 14(1):. PubMed ID: 29883322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.